These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 27522106)
1. Structural insight into the glucokinase-ligands interactions. Molecular docking study. Ermakova E Comput Biol Chem; 2016 Oct; 64():281-296. PubMed ID: 27522106 [TBL] [Abstract][Full Text] [Related]
2. Conformational transition pathway in the activation process of allosteric glucokinase. Huang M; Lu S; Shi T; Zhao Y; Chen Y; Li X; Liu X; Huang Z; Zhang J PLoS One; 2013; 8(2):e55857. PubMed ID: 23409066 [TBL] [Abstract][Full Text] [Related]
3. The use of docking-based comparative intermolecular contacts analysis to identify optimal docking conditions within glucokinase and to discover of new GK activators. Taha MO; Habash M; Khanfar MA J Comput Aided Mol Des; 2014 May; 28(5):509-47. PubMed ID: 24610240 [TBL] [Abstract][Full Text] [Related]
4. N-pyridin-2-yl benzamide analogues as allosteric activators of glucokinase: Design, synthesis, in vitro, in silico and in vivo evaluation. Grewal AS; Kharb R; Prasad DN; Dua JS; Lather V Chem Biol Drug Des; 2019 Mar; 93(3):364-372. PubMed ID: 30369030 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of novel thiazol-2-yl benzamide derivatives as glucokinase activators. Charaya N; Pandita D; Grewal AS; Lather V Comput Biol Chem; 2018 Apr; 73():221-229. PubMed ID: 29518630 [TBL] [Abstract][Full Text] [Related]
6. Binding kinetics of glucose and allosteric activators to human glucokinase reveal multiple conformational states. Antoine M; Boutin JA; Ferry G Biochemistry; 2009 Jun; 48(23):5466-82. PubMed ID: 19459610 [TBL] [Abstract][Full Text] [Related]
7. The active conformation of human glucokinase is not altered by allosteric activators. Petit P; Antoine M; Ferry G; Boutin JA; Lagarde A; Gluais L; Vincentelli R; Vuillard L Acta Crystallogr D Biol Crystallogr; 2011 Nov; 67(Pt 11):929-35. PubMed ID: 22101819 [TBL] [Abstract][Full Text] [Related]
8. Comparative docking assessment of glucokinase interactions with its allosteric activators. Kumari V; Li C Curr Chem Genomics; 2008 Dec; 2():76-89. PubMed ID: 20161845 [TBL] [Abstract][Full Text] [Related]
9. Ligand-based modeling followed by in vitro bioassay yielded new potent glucokinase activators. Taha MO; Habash M; Hatmal MM; Abdelazeem AH; Qandil A J Mol Graph Model; 2015 Mar; 56():91-102. PubMed ID: 25574766 [TBL] [Abstract][Full Text] [Related]
10. Identification and analysis of novel R308K mutation in glucokinase of type 2 diabetic patient and its kinetic correlation. Yellapu NK; Valasani KR; Pasupuleti SK; Gopal S; Potukuchi Venkata Gurunadha Krishna S; Matcha B Biotechnol Appl Biochem; 2014; 61(5):572-81. PubMed ID: 24447076 [TBL] [Abstract][Full Text] [Related]
11. Discovery of Small-Molecule Glucokinase Regulatory Protein Modulators That Restore Glucokinase Activity. Chen K; Michelsen K; Kurzeja RJ; Han J; Vazir M; St Jean DJ; Hale C; Wahl RC J Biomol Screen; 2014 Aug; 19(7):1014-23. PubMed ID: 24717911 [TBL] [Abstract][Full Text] [Related]
12. Molecular modeling and identification of novel glucokinase activators through stepwise virtual screening. Behera PM; Behera DK; Satpati S; Agnihotri G; Nayak S; Padhi P; Dixit A J Mol Graph Model; 2015 Apr; 57():122-30. PubMed ID: 25723349 [TBL] [Abstract][Full Text] [Related]
13. 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase and small chemical activators affect enzyme activity of activating glucokinase mutants by distinct mechanisms. Langer S; Hofmeister-Brix A; Waterstradt R; Baltrusch S Biochem Pharmacol; 2019 Oct; 168():149-161. PubMed ID: 31254492 [TBL] [Abstract][Full Text] [Related]
14. Determinants of human glucokinase activation and implications for small molecule allosteric control. Li Q; Gakhar L; Ashley Spies M Biochim Biophys Acta Gen Subj; 2018 Sep; 1862(9):1902-1912. PubMed ID: 29885360 [TBL] [Abstract][Full Text] [Related]